Found 192 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer PHASE2 Our study is a prospective, non-inferior, randomized phase II clinical tria...
Show More Location
Multiple Locations
Learn More & Join Trial
Adjuvant FEC Versus EP in Breast Cancer (MIG5) PHASE3 In this multicenter, randomized phase III trial, node positive early breast...
Show More Location
Federico Castiglione
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) PHASE2 The present clinical trial will investigate the safety and efficacy of a se...
Show More Location
Ludwig Maximillian University Munich, Department of Gynecology and Obstetrics
Learn More & Join Trial
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency PHASE3 The purpose of this trial is to compare the 3-year disease-free survival of...
Show More Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) PHASE3 This study is a randomized, double-Blind,international multi-Centre, phase ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer PHASE2 This is an open-label, multicenter international trial in men and women wit...
Show More Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence
Learn More & Join Trial
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial PHASE2 VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...
Show More Status
Active Not Recruiting
Learn More & Join Trial